1. Home
  2. PRAX vs STRL Comparison

PRAX vs STRL Comparison

Compare PRAX & STRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$325.47

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Sterling Infrastructure Inc.

STRL

Sterling Infrastructure Inc.

HOLD

Current Price

$420.28

Market Cap

9.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
STRL
Founded
2015
1955
Country
United States
United States
Employees
N/A
1740
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.4B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
PRAX
STRL
Price
$325.47
$420.28
Analyst Decision
Strong Buy
Buy
Analyst Count
15
3
Target Price
$572.13
$443.33
AVG Volume (30 Days)
364.5K
531.7K
Earning Date
05-12-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
13.42
EPS
N/A
9.38
Revenue
N/A
$957,958,000.00
Revenue This Year
N/A
$20.76
Revenue Next Year
$6,395.88
$11.64
P/E Ratio
N/A
$44.36
Revenue Growth
N/A
38.81
52 Week Low
$26.70
$96.34
52 Week High
$354.87
$477.03

Technical Indicators

Market Signals
Indicator
PRAX
STRL
Relative Strength Index (RSI) 53.52 54.32
Support Level $290.36 $303.13
Resistance Level N/A $470.00
Average True Range (ATR) 18.34 28.62
MACD -2.56 -4.21
Stochastic Oscillator 57.24 31.95

Price Performance

Historical Comparison
PRAX
STRL

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About STRL Sterling Infrastructure Inc.

Sterling Infrastructure Inc is a construction company that specializes in heavy civil infrastructure construction and infrastructure rehabilitation as well as residential construction projects. The company operates in three reportable segments namely, Transportation Solutions, E-Infrastructure Solutions, and Building Solution. Transportation Solutions include highways, roads, bridges, airfields, ports, light rail, and others. Building Solution projects include concrete foundations for single-family homes. E-Infrastructure Solutions include the services which are provided to large, blue-chip companies in the e-commerce, data center, distribution center, and warehousing, energy, mixed-use, and multi-family sectors. The majority of the revenue is generated from E-Infrastructure Solutions.

Share on Social Networks: